CCL22 and COVID-19: In contrast, levels of CCL17 (also known as TARC) and CCL22 (also known as MDC) were reduced in COVID-19 patients relative to HVs, with an inverse association observed between CCL22, but not CCL17, levels and COVID-19 severity.